The claimed invention relates to methods of modulating mucin synthesis and
the therapeutic application of compounds in controlling mucin
over-production associated with diseases such as chronic obstructive
pulmonary diseases (COPD) including asthma and chronic bronchitis,
inflammatory lung diseases, cystic fibrosis and acute or chronic
respiratory infectious diseases.
